ARFI Variance of Acceleration for Diagnostic Breast Cancer Imaging in Women, in vivo

Author(s):  
Anna V. Phillips ◽  
Gabriela Torres ◽  
Doreen Steed ◽  
Melissa C. Caughey ◽  
Jasmin Merhout ◽  
...  
2012 ◽  
Vol 35 (5-6) ◽  
pp. 317-337 ◽  
Author(s):  
Yasaman Ardeshirpour ◽  
Amir H. Gandjbakhche ◽  
Laleh Najafizadeh

In vivooptical imaging is being conducted in a variety of medical applications, including optical breast cancer imaging, functional brain imaging, endoscopy, exercise medicine, and monitoring the photodynamic therapy and progress of neoadjuvant chemotherapy. In the past three decades,in vivodiffuse optical breast cancer imaging has shown promising results in cancer detection, and monitoring the progress of neoadjuvant chemotherapy. The use of near infrared spectroscopy for functional brain imaging has been growing rapidly. In fluorescence imaging, the difference between autofluorescence of cancer lesions compared to normal tissues were used in endoscopy to distinguish malignant lesions from normal tissue or inflammation and in determining the boarders of cancer lesions in surgery. Recent advances in drugs targeting specific tumor receptors, such as AntiBodies (MAB), has created a new demand for developing non-invasivein vivoimaging techniques for detection of cancer biomarkers, and for monitoring their down regulations during therapy. Targeted treatments, combined with new imaging techniques, are expected to potentially result in new imaging and treatment paradigms in cancer therapy. Similar approaches can potentially be applied for the characterization of other disease-related biomarkers. In this chapter, we provide a review of diffuse optical and fluorescence imaging techniques with their application in functional brain imaging and cancer diagnosis.


2002 ◽  
Vol 29 (8) ◽  
pp. 809-815 ◽  
Author(s):  
Holger Palmedo ◽  
Jenne Hensel ◽  
Michael Reinhardt ◽  
Dirk Von Mallek ◽  
Alexander Matthies ◽  
...  

2018 ◽  
Vol 11 (3) ◽  
pp. 65
Author(s):  
Alicia Vall-Sagarra ◽  
Shanna Litau ◽  
Clemens Decristoforo ◽  
Björn Wängler ◽  
Ralf Schirrmacher ◽  
...  

2011 ◽  
Vol 2011 ◽  
pp. 1-7 ◽  
Author(s):  
Fan-Lin Kong ◽  
Mohammad S. Ali ◽  
Yinhan Zhang ◽  
Chang-Sok Oh ◽  
Dong-Fang Yu ◽  
...  

Purpose. This study was to develop an efficient synthesis of99mTc-O-[3-(1,4,8,11-tetraazabicyclohexadecane)-propyl]-α-methyl tyrosine (99mTc-N4-AMT) and evaluate its potential in cancer imaging.Methods. N4-AMT was synthesized by reacting N4-oxalate and 3-bromopropyl AMT (N-BOC, ethyl ester).In vitrocellular uptake kinetics of99mTc-N4-AMT was assessed in rat mammary tumor cells. Tissue distribution of the radiotracer was determined in normal rats at 0.5–4 h, while planar imaging was performed in mammary tumor-bearing rats at 30–120 min.Results. The total synthesis yield of N4-AMT was 14%. Cellular uptake of99mTc-N4-AMT was significantly higher than that of99mTc-N4. Planar imaging revealed that99mTc-N4-AMT rendered greater tumor/muscle ratios than99mTc-N4.Conclusions. N4-AMT could be synthesized with a considerably high yield. Ourin vitroandin vivodata suggest that99mTc-N4-AMT, a novel amino acid-based radiotracer, efficiently enters breast cancer cells, effectively distinguishes mammary tumors from normal tissues, and thus holds the promise for breast cancer imaging.


2013 ◽  
Author(s):  
Nicholas J. Kenney ◽  
Drew Weisenberger ◽  
Richard Brittan ◽  
Benjamin Welch

Author(s):  
Halil Kömek ◽  
Canan Can ◽  
Yunus Güzel ◽  
Zeynep Oruç ◽  
Cihan Gündoğan ◽  
...  

2020 ◽  
Vol 15 (1) ◽  
Author(s):  
Zhenhui Nie ◽  
Ningbin Luo ◽  
Junjie Liu ◽  
Xinyi Zeng ◽  
Yu Zhang ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document